Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Keyword
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Contains 4 Component(s) Includes a Live Web Event on 10/17/2024 at 1:00 AM (EDT)

    Cases to be announced.

    NCC - 10/2024

    Cases to be announced.


    Series Moderator: Lewis Nelson, MD, FACMT, Rutgers New Jersey Medical School, Newark, NJ

    About The Series: ACMT's National Case Conference (NCC) is a monthly webinar for ACMT members that features interesting cases seen by medical toxicologists nationwide. NCC is an educational endeavor and a quality improvement effort intended to improve patient care. It is not intended to define standard of care. Attempts have been made to ensure HIPAA compliance. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.

    This webinar is for ACMT members only.

    Lewis Nelson, MD, MBA, FACMT, FASAM

    Chair of Emergency Medicine

    Rutgers New Jersey Medical School

    Lewis S. Nelson, MD is Professor and Chair of the Department of Emergency Medicine at Rutgers New Jersey Medical School, Chief of Service for the Emergency Department at University Hospital of Newark, and Senior Consultant to the New Jersey Poison Information & Education System. Dr. Nelson is board certified in emergency medicine, medical toxicology, and addiction medicine. His areas of specific interest include preventing and managing the consequences of opioid and other substance use, multimodal pain management strategies, health policy, and medication safety.

    Dr. Nelson has served as President of American College of Medical Toxicology and on the Board of Directors of both the American Board of Emergency Medicine and the Accreditation Council for Continuing Medical Education. He is currently the president of Association of Academic Chairs in Emergency Medicine. He is a long time consultant for several governmental agencies including the Centers for Disease Control and Prevention, the Department of Homeland Security, and the Food and Drug Administration. He is an editor of the textbook “Goldfrank’s Toxicologic Emergencies.

  • Contains 4 Component(s) Includes a Live Web Event on 08/15/2024 at 1:00 PM (EDT)

    Cases to be announced.

    NCC - 8/2024

    Cases to be announced.


    Series Moderator: Lewis Nelson, MD, FACMT, Rutgers New Jersey Medical School, Newark, NJ

    About The Series: ACMT's National Case Conference (NCC) is a monthly webinar for ACMT members that features interesting cases seen by medical toxicologists nationwide. NCC is an educational endeavor and a quality improvement effort intended to improve patient care. It is not intended to define standard of care. Attempts have been made to ensure HIPAA compliance. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.

    This webinar is for ACMT members only.

    Lewis Nelson, MD, MBA, FACMT, FASAM

    Chair of Emergency Medicine

    Rutgers New Jersey Medical School

    Lewis S. Nelson, MD is Professor and Chair of the Department of Emergency Medicine at Rutgers New Jersey Medical School, Chief of Service for the Emergency Department at University Hospital of Newark, and Senior Consultant to the New Jersey Poison Information & Education System. Dr. Nelson is board certified in emergency medicine, medical toxicology, and addiction medicine. His areas of specific interest include preventing and managing the consequences of opioid and other substance use, multimodal pain management strategies, health policy, and medication safety.

    Dr. Nelson has served as President of American College of Medical Toxicology and on the Board of Directors of both the American Board of Emergency Medicine and the Accreditation Council for Continuing Medical Education. He is currently the president of Association of Academic Chairs in Emergency Medicine. He is a long time consultant for several governmental agencies including the Centers for Disease Control and Prevention, the Department of Homeland Security, and the Food and Drug Administration. He is an editor of the textbook “Goldfrank’s Toxicologic Emergencies.

  • Contains 4 Component(s) Includes a Live Web Event on 08/13/2024 at 12:00 PM (EDT)

    Methamphetamines

    Methamphetamines

    Presenter: Petros Levounis, MD, MA, Professor and Chair, Department of Psychiatry, and Associate Dean, Rutgers New Jersey Medical School, Newark, NJ

    Learning Objectives

    • To be announced

    About The Series: ACMT's Grand Rounds offer an in-depth and interactive platform for learning and discussion about issues that impact the research and practice of medical toxicology. Experts from within and outside medical toxicology will share their knowledge and experience and highlight areas for collaboration and mutual understanding.

    This webinar is for ACMT members only.

    Petros Levounis, MD, MA

    Professor and Chair, Department of Psychiatry, and Associate Dean

    Rutgers New Jersey Medical School

    Petros Levounis, MD, MA, serves as professor and chair of the Department of Psychiatry and associate dean at Rutgers New Jersey Medical School. He is also the chief of service at University Hospital in Newark, New Jersey, director of the Northern New Jersey Medications for Addiction Treatment Center of Excellence, and president of the American Psychiatric Association. 

    Dr. Levounis completed his undergraduate work at Stanford University where he studied chemistry and biophysics before receiving his medical education at Stanford University School of Medicine and the Medical College of Pennsylvania. During medical school, he researched the effects of social class on patient-physician relationships in Oxford, England, and received an MA degree in sociology from Stanford. He then graduated from the Columbia University Psychiatry Residency program earning the National Institute of Mental Health Outstanding Resident Award and went on to complete his fellowship in addiction psychiatry at New York University.

    Dr. Levounis has published fourteen books including the self-help paperback “Sober Siblings: How to Help Your Alcoholic Brother or Sister—and Not Lose Yourself” and the textbook of “Substance Dependence and Co Occurring Psychiatric Disorders.” His books have been translated into French, German, Hungarian, Japanese, Korean, Portuguese, and Spanish.

  • Contains 4 Component(s) Includes a Live Web Event on 07/18/2024 at 1:00 PM (EDT)

    Cases to be announced.

    NCC - 7/2024

    Cases to be announced.


    Series Moderator: Lewis Nelson, MD, FACMT, Rutgers New Jersey Medical School, Newark, NJ

    About The Series: ACMT's National Case Conference (NCC) is a monthly webinar for ACMT members that features interesting cases seen by medical toxicologists nationwide. NCC is an educational endeavor and a quality improvement effort intended to improve patient care. It is not intended to define standard of care. Attempts have been made to ensure HIPAA compliance. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.

    This webinar is for ACMT members only.

    Lewis Nelson, MD, MBA, FACMT, FASAM

    Chair of Emergency Medicine

    Rutgers New Jersey Medical School

    Lewis S. Nelson, MD is Professor and Chair of the Department of Emergency Medicine at Rutgers New Jersey Medical School, Chief of Service for the Emergency Department at University Hospital of Newark, and Senior Consultant to the New Jersey Poison Information & Education System. Dr. Nelson is board certified in emergency medicine, medical toxicology, and addiction medicine. His areas of specific interest include preventing and managing the consequences of opioid and other substance use, multimodal pain management strategies, health policy, and medication safety.

    Dr. Nelson has served as President of American College of Medical Toxicology and on the Board of Directors of both the American Board of Emergency Medicine and the Accreditation Council for Continuing Medical Education. He is currently the president of Association of Academic Chairs in Emergency Medicine. He is a long time consultant for several governmental agencies including the Centers for Disease Control and Prevention, the Department of Homeland Security, and the Food and Drug Administration. He is an editor of the textbook “Goldfrank’s Toxicologic Emergencies.

  • CE Credit available
    Contains 2 Component(s) Includes a Live Web Event on 07/12/2024 at 1:00 PM (EDT)

    Novel Use of Naltrexone For Alcohol Use Disorder

    Novel Use of Naltrexone For Alcohol Use Disorder

    Cases:

    1. Use of Naltrexone and Initiation in the ED/Hospital Setting

    2. "Pre-Exposure Prophylaxis" - Use of Naltrexone PRN For Individuals at Weddings or Similar Events


    About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.

    This webinar is open to the public.

    Continuing Education credits are now available for this activity! Click here for more info.

    Timothy Wiegand, MD, DFASAM, FACMT, FAACT (Moderator)

    Director of Addiction Medicine and Addiction Medicine Consults

    University of Rochester Medical Center

    Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center in Rochester New York.  He is Board Certified in Medical Toxicology and Addiction Medicine and practices in Addiction Toxicology with a mix of clinical,  research, teaching, and other professional work.  Dr. Wiegand has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and he is currently serving on the Board of Directors for the American Society of Addiction Medicine (ASAM) completing a term on the Executive Counsel as Vice President of ASAM.  He begins a two-year term as Treasurer of ASAM in April 2023.  Dr. Wiegand founded and led the Toxicology service at URMC until 2022 when he became Director of Addiction Medicine and Director of Addiction Medicine Consults also at URMC in the Department of Emergency Medicine.  Dr. Wiegand has served as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and he is the Fellowship Director for the URMC Medical Toxicology fellowship expecting to formally begin once accredited, in July of 2023.

    Gloria Baciewicz, MD (Moderator)

    Addiction Psycharcist

    Strong Recovery

    Since 1986, Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.

    Eve Andersen-Buescher, PMHNP-BC

    Senior Psychiatric Nurse Practitioner

    University of Rochester Medical Center

    Eve Andersen-Buescher has been working in the mental health field since 1986, beginning as a BSN, obtaining her MSN in 1990 and her post-master’s degree in 2015. She joined Strong Recovery in 2006 and has continued her work as a PMHNP-BC in mental health and addiction since that time. She is currently the Medical Services Coordinator at Strong Recovery, a Senior Psychiatric Nurse Practitioner and Lead APP.  She often presents on topics related to addiction and mental health both internally and in the community.

    Evan Schwarz, MD, FACMT

    Associate Professor of Emergency Medicine

    University of California, Los Angeles

    Dr. Schwarz attended medical school at the University of Texas Medical Branch in Galveston, Texas, before completing a residency in Emergency Medicine at the Washington University School of Medicine in Saint Louis, Missouri.  After residency, he completed a fellowship in Medical Toxicology at the University of Texas Southwestern School of Medicine in Dallas, Texas, before returning to Missouri where he was an Advisory Dean and the Medical Toxicology Division Chief and Fellowship Director at Washington University. In 2023, he took a position in the Department of Emergency Medicine at the University of California Los Angeles. He is also a member of the Board of Directors for ACMT.

    Richard Scott Dent, MD

    Clinical Senior Instructor

    University of Rochester Medical Center, Rochester, NY

    Continuing Education
    image

    Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare, and is available for an additional fee ($20 administrative fee per certificate).

    image

    In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    image

    This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.




    Physicians
    AKH Inc., Advancing Knowledge in Healthcare designates this live virtual activity and enduring activity material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For physicians, hours of participation are the number of AMA PRA Category 1 Credit(s)™ awarded.

    Nurses
    Credit being awarded:1.25 ANCC contact hours.


    Commercial Support
    There is no commercial support for this activity.


    Timothy J. Wiegand, MD, FACMT, DFASAM, Lead Physician Planner/Reviewer/Faculty: has nothing to disclose.
    Gloria J. Baciewicz, MD, Physician Planner/Reviewer/Faculty: has nothing to disclose.
    Eve Andersen-Buescher, PMHNP-BC, Faculty: has nothing to disclose.

    Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner/Reviewer: has nothing to disclose.
    Bernadette Marie Makar, MSN, NP-C, APRN-C, Nurse Planner/Reviewer: has nothing to disclose.
    AKH Planners and Reviewers: have nothing to disclose.

    None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

    All of the relevant financial relationships listed for these individuals have been mitigated.


    Disclosures

    It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

    Disclosure of Unlabeled Use and Investigational Product 

    This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer 

    This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.comwith your information with "Opt Out" in the subject line.


    Learner Notifications:

    Live Activity

    • Register
      • Non-member - Tier I - Free!
      • Non-member - Tier II - Free!
      • Non-member - Tier III - Free!
      • Non-member - Tier IV - Free!
      • Member - Tier I - Free!
      • Member - Tier II - Free!
      • Member - Tier III - Free!
      • Member - Tier IV - Free!
    • More Information
  • CE Credit available
    Contains 81 Component(s), Includes Credits Includes Multiple Live Events. The next is on 06/28/2024 at 12:00 PM (EDT)

    On-Demand Prep Course for MedTox Certification Exam

    2024 ACMT Board Review Course

    The 2024 ACMT Board Review Course is back with an innovative twist for your learning experience! This online course is designed to prepare all examinees for the biennial certification examination in Medical Toxicology administered by the American Board of Emergency Medicine (ABEM). Led by prominent experts in the field of medical toxicology, you will receive a broad overview of the scope of the specialty and a detailed perspective into current clinical and public health toxicological issues.

    Register today! Access to course content begins: June 1, 2024

    Learner Objectives:

    1. Identify and review core topic areas in the specialty of Medical Toxicology.
    2. Prepare for common test questions and terms that may be found on a Medical Toxicology certification exam.
    3. Discuss initial management and standard treatment approaches of patients with toxicologic issues. 


    The Flipped Classroom Advantage

    Get prepared for the ABEM certification exam with our new Flipped Classroom format - the ultimate fusion of convenience, flexibility, and interactivity. In a departure from conventional learning approaches, our Flipped Classroom (a blended learning format) will give you access to a comprehensive array of 30+ meticulously curated on-demand lectures encompassing the entire spectrum of medical toxicology. This enriched content will be at your disposal June 1, 2024 - May 31, 2025, empowering you to proceed with your studies at a pace that aligns with your commitments.

    Interactive Cram Sessions

    In addition to the autonomous learning, prepare to be part of 7 live, interactive cram sessions throughout the summer and early fall. Focused on 4-5 core topics during each session, these power-packed sessions are your golden ticket to in-depth insights, key takeaways, and invaluable Q&A with our experts.

    Unparalleled Lectures

    Our top-notch speakers are ready to guide you through each lecture, ensuring you grasp every critical concept. These lectures are pre-recorded so you can access them anytime, anywhere and as many times as you want until you are confident in each subject area. Immerse yourself in a learning journey with lectures that drill down into each aspect of the Medical Toxicology Core Content including:

    Alcohols & GlycolsDrugs of Abuse & Withdrawal
    Pediatric Toxicity
    Analytics & ForensicsEndocrine
    Pesticides
    Anesthetics, NMBs & Muscle RelaxantsEpidemiology & Population HealthPharmaco & Toxicokinetics
    AntimicrobialsGastroenterology
    Poisonous Plants
    Antipsychotics
    HematologyPsychotropics
    Aquatic ToxicityHerbals, Vitamins & Supplements
    Radiation
    CarcinogenesisHydrocarbons
    Reproductive & Developmental Tox
    Cardiovascular ToxinsInhalational Toxins & Asphyxiants
    Statistical Measures
    ChemotherapeuticsMetals & Metalloids
    Terrestrial Toxicity
    Classic Toxicology
    Miscellaneous Toxins
    The Toxic House
    Clinical Drug Testing & DiagnosticsMushrooms & Fungal ToxinsWarfare/Terrorism
    Dermatology & PathologyNeurotoxins & Anticonvulsants
    Study Resources 

    In addition to an on-demand library of medical toxicology core lectures, avail yourself of this courses additional study resources. Click here for more info!


    Questions?

    Please write to ACMT at events@acmt.net

    Registration Rates

    Registration CategoriesFees

    ACMT Members

    $1500

    Non-Members

    $1750


    Registration includes:

    • Access to the on-demand content: June 1, 2024 - May 31, 2025
    • Access to 7 interactive cram sessions - live Q&A with the speakers
    • Access to PDFs of the lecture slides & handouts
    • Access to Quiz Bank
    • Access to online Flashcards
    • 26.00 Continuing Medical Education credits (Physician Only)



    ACMT Membership

    ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Manager at membership@acmt.net. Learn more at: www.acmt.net/membership


    Continuing Education

    Continuing Medical Education (CME) for this activity is included in the registration fee (at no additional cost). AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for 26.0 AMA PRA Category 1 Credit(s)™. Physicians may claim only the credit commensurate with the extent of their participation in the activity. No partial credit will be awarded.


    Print Materials

    Prefer to study with hardcopies? Print slide books and print flashcards are available for purchase. Click on the buttons below for more info:

    Print Slide Book     Print Flashcards


    Cancellation Policy

    Cancellations made on or before May 16, 2024 will receive a full refund less an 8% processing fee. Cancellations made after this date will not receive a refund. Limited exceptions may be considered for emergency situations pending review.

    All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.

    Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to events@acmt.net. Because each exception must undergo a review and approval process, we ask in advance for your patience.

    Click here to read ACMT's full cancellation policy.


    Questions?

    Write to: events@acmt.net

    Study Resources

    When you register for this course, we'll arm you with an arsenal of study resources. Dive into the Quiz Bank to put your knowledge to the test, flip through flashcards for rapid-fire revision, and explore visual stimuli to enhance your understanding. The ACMT Board Review Course includes:

    Study Materials: slides, handouts, and supplementary materials 
    Flashcards: 350+ flashcards to help you study keywords and concepts
    Quiz Bank: 925 example test questions on a variety of toxicological topics to help you prepare for certification. Try out the new Mock Exam!

    Disclaimer: according to ABEM policy, the planning committee and faculty for this course are not allowed to have intimate knowledge of the exam or write exam questions. The content of this course is based on the expertise of ACMT members, who are specialists in Medical Toxicology. We do not have direct knowledge of the exam content. ABEM test question writers are prohibited from participating in any board review or preparatory course. The study materials, including the Quiz Bank questions, are based on years of collective experience from the Board Review Course committee, but we do not guarantee that these questions fully represent the exam content.


    Print Material Add-Ons

    Prefer studying with hardcopies? For an additional fee, we have print versions of the Study Materials and Flashcards that we can ship directly to your home or office.

    Purchase Print Slide Book     Purchase Print Flashcards

    Continuing Education

    image

    Continuing Education credit for this activity has been approved and is provided by AKH Inc., Advancing Knowledge in Healthcare.

    Release date: June 1, 2024
    Expiration date: May 31, 2025


    Activity Overview
    The 2024 ACMT Board Review Course is back with an innovative twist for your learning experience! This online course is designed to prepare all examinees for the biennial certification examination in Medical Toxicology administered by the American Board of Emergency Medicine (ABEM). Led by prominent experts in the field of medical toxicology, you will receive a broad overview of the scope of the specialty and a detailed perspective into current clinical and public health toxicological issues.

    Target Audience
    This activity is designed for an audience of physicians.

    Learning Objectives
    Upon completion of the educational activity, participants should be able to:

    1. Identify and review core topic areas in the specialty of Medical Toxicology.
    2. Prepare for common test questions and terms that may be found on a Medical Toxicology certification exam.
    3. Discuss initial management and standard treatment approaches of patients with toxicologic issues.

    Criteria for Success
    Statements of credit will be awarded based on the participant's attendance.  A statement of credit will be available upon completion of all on-demand lectures, the 100 Q Practice Test, and CE Survey.   


    CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.

    In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Physicians
    AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 26.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


    Commercial Support
    There is no commercial support for this activity.

    Disclosures
    It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

    DISCLOSURES

    Name

    Relationship

    Commercial Interest

    Ann Arens, MD (faculty)

    N/A

    Nothing to disclose

    Jeffrey Brent, MD, PhD, FACMT (faculty)

    N/A

    Nothing to disclose

    Michele Burns, MD, FACMT (faculty)

    N/A

    Nothing to disclose

    Shaun D. Carstairs, MD, FACMT (faculty)

    N/A

    Nothing to disclose

    Leslie R. Dye, MD, FACMT, FASAM, FACCT (faculty)

    N/A

    Nothing to disclose

    Christina Hantsch, MD, FACEP, FAACT, FACMT (faculty)

    N/A

    Nothing to disclose

    Ashley Haynes, MD, FACEP (faculty)

    N/A

    Nothing to disclose

    Michael G. Holland, MD, FEAPCCT, FAACT, FACOEM, FACMT, FACEP (faculty)

    N/A

    Nothing to disclose

    Ziad Kazzi, MD, FAAEM, FACEP, FACMT, FAACT (faculty)

    N/A

    Nothing to disclose

    William "Russ" Kerns, II, MD, FACMT, FACEP (faculty)

    N/A

    Nothing to disclose

    Joshua D. King, MD, FACMT (faculty)

    N/A

    Nothing to disclose

    Kurt C. Kleinschmidt, MD, FACMT, FASAM (faculty)

    N/A

    Nothing to disclose

    Vincent R. Lee, MD (Moderator)

    N/A

    Nothing to disclose

    Michael Levine, MD, FACMT (Moderator)

    N/A

    Nothing to disclose

    Nima Maljesi, DO (faculty)

    N/A

    Nothing to disclose

    Christopher W. Meaden, MD, MS, FAAEM (Moderator)

    N/A

    Nothing to disclose

    Charles McKay, MD, FACMT (faculty)

    N/A

    Nothing to disclose

    Joshua Nogar, MD (faculty)

    N/A

    Nothing to disclose

    J.J. Rasimas, PhD, MD, FAACT, FACLP, FACMT, FACPsych (faculty)

    N/A

    Nothing to disclose

    Daniel J. Sessions, MD, FACMT, FASAM, FAAEM (faculty)

    N/A

    Nothing to disclose

    Sarah Shafer, MD (faculty)

    N/A

    Nothing to disclose

    Jerry W. Snow, MD (faculty)

    N/A

    Nothing to disclose

    Alaina R. Steck, MD, FACMT, FASAM (Moderator)

    N/A

    Nothing to disclose

    Samuel J. Stelpflug, MD, FACMT (faculty)

    N/A

    Nothing to disclose

    Joshua Trebach, MD (Moderator)

    N/A

    Nothing to disclose

    Stephanie Weiss, MD, PhD (faculty)

    N/A

    Nothing to disclose

    Dorothy Caputo, MA, BSN, RN - VP, Healthcare Continuing Education and Operations

    N/A

    Nothing to disclose

    Michele Bielarski, RN (planner/reviewer)

    N/A

    Nothing to disclose

    AKH Inc Staff and Planners

    N/A

    Nothing to disclose

    ACMT Staff and Planners

    N/A

    Nothing to disclose

    All of the relevant financial relationships listed for these individuals have been mitigated.

    Disclosure of Unlabeled Use and Investigational Product
    This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer
    This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with "Opt Out" in the subject line.

    Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

    Ann Arens, MD

    Emergency Medicine Physician

    Ochsner Medical Center

    Dr. Arens is an Emergency Medicine physician who practices at Ochsner Medical Center in New Orleans, LA. Dr. Arens completed her Emergency Medicine training at the Denver Health Residency in Emergency Medicine, and her medical toxicology training at the University of California – San Francisco. She was amongst the first toxicologists to identify and describe counterfeit fentanyl products, and has continued to identify outbreaks of new drugs of abuse. She has a broad range of research interests including: the identification of new drugs of abuse including novel opioids contributing to the current opioid epidemic, the use of antidotes, and advanced supportive care of the poisoned patient.

    Jeffrey Brent, MD, PhD, FACMT

    Distinguished Clinical Professor of Medicine (Pulmonary and Critical Care) and Emergency Medicine

    University of Colorado School of Medicine and Public Health

    Jeffrey Brent, M.D., Ph.D., is a Distinguished Clinical Professor of Medicine (Pulmonary and Critical Care Medicine) and Emergency Medicine at the University of Colorado Schools of Medicine and Public Health. He did his fellowship in medical toxicology at the Rocky Mountain Poison and Drug Center, where he has been both medical director and fellowship director. He is a former President of the American Academy of Clinical Toxicology and a former Board member of the American College of Medical Toxicology. Dr. Brent is the senior editor of Critical Care Toxicology: the Diagnosis and Management of the Critically Poisoned Patient, currently in its second edition. Dr. Brent is Co-Principal Investigator of ACMT’s Toxicology Investigators Consortium.

    Michele Burns, MD, FACMT

    Associate Physician

    Boston Children's Hospital

    Dr. Michele Burns is triple boarded in general pediatrics, pediatric emergency medicine, and medical toxicology. She has been the Medical Director of the Massachusetts and Rhode Island Poison Center for the last 20 years and is Chief of the Boston Children's Hospital Toxicology service. Her clinical research interests include investigating the epidemiological trends of pediatric poisoning exposures by using large hospital or national databases, and clinical communications that describe novel and innovative case presentations and/or treatment modalities in the pediatric toxicology patient. In addition, she is the Harvard Medical Toxicology Fellowship Director and a former member of both the ACMT Board and ABEM Medical Toxicology Subboard. Dr. Burns is also the Pediatric Toxicology Section Editor for UptoDate. She is committed to promoting optimal health care for acutely injured and poisoned patients, advocating for state-of-the-art treatment while contributing to national consensus guidelines and prevention efforts on a more global level.

    Shaun D. Carstairs, MD, FACMT

    Medical Toxicologist

    98point6, Inc.

    Dr. Carstairs earned his undergraduate degree from the California Institute of Technology in Pasadena, CA and received his medical degree from the Uniformed Services University of the Health Sciences (USU), the nation's military medical school.  He completed a residency in emergency medicine at the Naval Medical Center in San Diego and a fellowship in medical toxicology at the University of California, San Diego.  He served more than 25 years on active duty in the U.S. Navy, which included a combat deployment to Iraq and shipboard deployment as the leader of a mobile trauma team for the Navy’s Pacific Fleet. He retired from the Navy as a Captain in 2019. He currently serves as a faculty member in the Department of Emergency Medicine & Division of Medical Toxicology at the University of California, San Diego (UCSD). In addition to his role at UCSD, he holds an appointment as Professor of Military & Emergency Medicine at USU.

    Leslie R. Dye, MD, FACMT, FASAM, FACCT

    Interim Medical Director, OneFifteen

    Clinical Professor, Wright State University/Boonshoft School of Medicine

    Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.

    Christina Hantsch, MD, FACEP, FAACT, FACMT

    Emergency Physician and Medical Toxicologist

    Dr. Hantsch is a graduate of the Honors Program in Medical Education at Northwestern University. She completed an emergency medicine residency, including a year as chief resident, at the Medical College of Wisconsin and then continued her training in a medical toxicology fellowship at Vanderbilt University. After her fellowship, she spent nearly 22 years at Loyola University Chicago Stritch School of Medicine and Loyola University Medical Center. There, she established an inpatient toxicology clinical service and clinical rotations for graduate medical trainees and students in multiple fields. With an interest in medication management and safety, she joined the hospital Pharmacy and Therapeutics Committee, serving as member for 6 years before being appointed chair and leading the committee for another 6 years. Dr. Hantsch earned the academic rank of Professor of Emergency Medicine, was Director of the Division of Toxicology, and Director of Academic Affairs in the Department of Emergency Medicine. As a clinical faculty member, she was appointed to the Stritch Committee on Academic Rank and Tenure, serving for 7 years including 2 as a subcommittee chair leading revision of the clinician educator track guidelines. In 2018, she was the founding Program Director of the Loyola emergency medicine residency. Dr. Hantsch served for more than 8 years as Medical Director of the Illinois Poison Center. In addition, she is a regular organizer and contributor to many local, regional, and national/international continuing education programs. After leaving academics, she worked for the U.S. FDA in pharmacovigilance for a year. As of 2022, she is board certified in addiction medicine in addition to emergency medicine and medical toxicology. Dr. Hantsch was elected to the ACMT Board of Directors in 2021, is a member of the Education Committee, and chair of the Practice Committee.

    Ashley Haynes, MD, FACEP

    Medical Toxicologist, Addiction Medicine Specialist

    Veterans Health Administration

    Dr. Haynes completed training in a combined emergency medicine-internal medicine program in 2014, and a toxicology fellowship at UTSW in 2016. She has been treating substance use disorders as part of her practice since that time and is board certified in addition medicine. She currently works for the VA at the Robert J Dole Veterans Medical Center in Wichita, KS, treating patients in a residential treatment center, as well as clinic, and performing bedside consults.

    Michael G. Holland, MD, FEAPCCT, FAACT, FACOEM, FACMT, FACEP

    Professor of Emergency Medicine

    SUNY Upstate Medical University

    Dr. Holland is Clinical Professor of Emergency Medicine at SUNY Upstate Medical University in Syracuse, NY where he is on the faculty of the Medical Toxicology Fellowship Training Program and is a Consulting Medical Toxicologist at the Upstate New York Poison Center and the Onondaga County Medical Examiner’s Office-both in Syracuse, NY. Dr. Holland is also the Director of Occupational Medicine for the Saratoga Hospital Medical Group, and is the Saratoga Hospital Employee Health Medical Director, where he oversees the health and safety of over 3100 employees and staff. He also serves as Employee Health Medical Director at Glens Falls Hospital in Glens Falls, NY, covering 2500 employees. He is also Principal Medical Toxicologist at the Center for Toxicology and Environmental Health (CTEH) in Little Rock, AR.    

    Ziad Kazzi, MD, FAAEM, FACEP, FACMT, FAACT

    Professor, Department of Emergency Medicine

    Emory University School of Medicine

    Born in 1975 and raised in Beirut, Lebanon, Dr. Kazzi trained in Emergency Medicine at Emory University in Atlanta (2000-03) where he served as a chief resident before completing a subspecialty fellowship in Medical Toxicology at Emory University, Georgia Poison Center and the Centers for Disease Control and Prevention (CDC) in Atlanta. He is board certified in both Emergency Medicine and Medical Toxicology. Dr. Kazzi joined the Department of Emergency Medicine at the University of Alabama at Birmingham (UAB) between 2005 and 2008 where he served as a Medical Toxicologist for the Regional Poison Control Center in Birmingham and the Alabama Poison Center. Currently, he is an associate professor at the department of Emergency Medicine at Emory University in Atlanta, Georgia as well as the director of the International Toxicology Postdoctoral Fellowship Program at Emory University (http://www.em.emory.edu/services/toxicology/international_postdoc_training.html). He is also the assistant medical director of the Georgia Poison Center (www.georgiapoisoncenter.org) and a medical toxicologist at the Radiation Studies Branch of the National Center for Environmental Health at the CDC (https://www.cdc.gov/nceh/radiation/) where he participates in emergency preparedness and response activities in radiation. As an emergency physician and toxicologist, Dr. Kazzi specializes in the recognition, triage, and management of poisonings and holds a deep interest in the areas of Radiation and International Toxicology. Over the past decade, he developed strong ties to India in the areas of medical toxicology, mass gathering medical preparedness, radiation emergency medicine, blast injuries and hazmat. Through his collaboration with the CDC, AIIMS, and PGIMER Chandigarh, he has delivered and co-directed the first Advanced Hazmat Life Support trainings in Ahmedabad and Delhi. He organized a number of training conferences in Nashik, Pune, Ujjain and Delhi and has been an invited speaker at the annual INDUS EM world congress. He is an active and founding board member of the Middle East North Africa Toxicology Association (www.menatox.org) and currently serves as its President. He is also a board member and chairs the International Committee of the American College of Medical Toxicology (www.acmt.net).

    William "Russ" Kerns, II, MD, FACMT, FACEP

    Emeritus Professor of Emergency Medicine

    Carolinas Medical Center

    Dr. Kerns trained in Emergency Medicine and Medical Toxicology and served as Professor in both disciplines at Carolinas Medical Center for 33 years. Faculty roles included leadership of the Medical Toxicology Fellowship and clinical division, consultation for the Carolinas Poison Center, and research. Research interests included antidotes, envenomation, and resuscitation of cardiotoxic drugs. He also served the ACMT focusing on advancing research and education.

    Joshua D. King, MD, FACMT

    Associate Professor, Medicine and Pharmacy; Medical Director, Maryland Poison Center

    University of Maryland School of Medicine

    Dr. King received his medical education from Penn State College of Medicine, and completed Internal Medicine residency and chief residency at the University of Virginia. He completed Nephrology fellowship at Johns Hopkins Hospital, and after returning to the University of Virginia as a nephrologist, completed a medical toxicology fellowship there. Dr. King is a clinician-educator nephrologist and medical toxicologist with clinical interests in extracorporeal treatment of poisonings, extracorporeal removal of therapeutic drugs, ICU nephrology, and medical education. As a clinician, he sees hospitalized patients at the University of Maryland Medical Center on our nephrology consultation service as well as our medical toxicology consult service. He is involved in education primarily at the graduate medical education level, and to a lesser extent undergraduate medical education. Dr. King is also the medical director of the Maryland Poison Center, which provides poisoning information and treatment recommendations benefitting thousands of Marylanders each year. Dr. King carries out medical oversight of recommendations for poisonings, envenomations, and overdoses to the public and health care providers; provides education to a variety of students (pharmacy and medical) and physicians (residents and fellows) who rotate with the center; he is involved in a variety of other activities aimed at treatment and prevention of poisoning. Dr. King's research interests are largely focused where nephrology and toxicology meet – extracorporeal removal of toxins (via dialysis, apheresis, and other modalities).

    Kurt C. Kleinschmidt, MD, FACMT, FASAM

    Professor of Emergency Medicine

    University of Texas Southwestern Medical Center

    Kurt C. Kleinschmidt, MD, FACMT, FASAM is a Professor of Emergency Medicine at the University of Texas Southwestern Medical Center in Dallas, Texas. He is a faculty member in the Division of Medical Toxicology. His areas of interest include Substance Use Disorders and snake envenomations. He graduated from the University of South Florida College of Medicine in 1986, completed his emergency medicine residency at Madigan Army Medical Center in 1990, and finished a clinical fellowship in Medical Toxicology at the University of Texas Southwestern Medical Center in 1999. He is board certified in Emergency Medicine (1991), Medical Toxicology (2002), and Addiction Medicine (2016). He became the Medical Director of the Perinatal Intervention Program in Parkland Health and Hospital system in 2016. He served as the Toxicology Program Director from 2004-2018 and as the Toxicology Division Chief from 2004-2020.

    Vincent R. Lee, MD (Moderator)

    Assistant Professor

    Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

    Dr. Lee is an emergency medicine physician at Glen Cove Hospital and medical toxicology attending for Northwell Health. He received his medical degree from SUNY Downstate in Brooklyn, NY, in 2015, completed his emergency medicine residency at Morristown Medical Center in Morristown, NJ, in 2018, and his Medical Toxicology Fellowship at Northwell Health in Long Island, NY, in 2020. He is board-certified in emergency medicine and medical toxicology. 

    Michael Levine, MD, FACMT (Moderator)

    Co-Division Chief of Medical Toxicology

    University of California, Los Angeles

    Michael Levine is a Los Angeles native, who completed his emergency medicine residency at the Harvard Affiliated Emergency Medicine program, based out of Brigham and Women’s Hospital and Massachusetts General Hospital. After residency, he completed his medical toxicology fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ. After staying as faculty for a year in Phoenix, he moved back to Los Angeles, where he joined the faculty at USC. He is currently the division chief of medical toxicology. He is actively involved in patient care, research, and serves on numerous hospital and university committees. He is an active member of American College of Emergency Physicians, the American College of Medical Toxicology, and is a member of the Toxicology Investigator's Consortium.

    Nima Maljesi, DO

    Director of Medical Toxicology

    Staten Island University Hospital Emergency Department

    Dr. Nima Majlesi completed Emergency Medicine Residency at Morristown Medical center in Morristown, NJ, in 2007, and went on to complete fellowship in medical toxicology at Northshore University hospital (now Northshore University hospital at Northwell) in Manhasset, NY, in 2009. Dr. Majlesi is board certified in Emergency medicine, medical toxicology and addiction medicine. In addition to initiating a 24/7 medical toxicology consultation service, he is the chair of the hospital pharmacy and therapeutics committee and helped initiate a program to initiate buprenorphine in the emergency department. He has been involved in creating guidelines regarding opioid prescribing for New York City, National emergency medicine organizations as well as his own institution. Education has been the main focus of his career.

    Christopher W. Meaden, MD, MS, FAAEM (Moderator)

    Assistant Professor of Emergency Medicine

    Rutgers New Jersey Medical School

    Dr. Christopher Meaden is Assistant Professor of Emergency Medicine at Rutgers New Jersey Medical School and a Medical Toxicology Consultant for the New Jersey Poison Information and Education System. He completed his residency training in emergency medicine at St. Joseph’s University Medical Center in Paterson, NJ and completed his medical toxicology fellowship as the inaugural fellow at Rutgers New Jersey Medical School. He is board certified in emergency medicine and medical toxicology. Dr. Meaden has a Master of Science degree in molecular and cellular biology. His interests include education in medical toxicology, acute care of the poisoned patient and chemical agents of war. He is involved with the American College of Medical Toxicology Education Committee and previously served as the associate chair for the 2022 and 2023 ACMT Annual Scientific Meeting. 

    Charles McKay, MD, FACMT

    Associate Medical Director

    CT Poison Control Center, University of Connecticut School of Medicine

    Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and -drug-induced impairment.

    Joshua Nogar, MD

    Director of Medical Toxicology, Medical Toxicology Fellowship Director

    Hofstra/Northwell Health

    Dr. Josh Nogar grew up in the High Desert of New Mexico, but has been a New Yorker for 16 years. Dr. Nogar received his medical degree from the New York University School of Medicine in 2005, completed a residency in Emergency Medicine at the University of New Mexico in 2009, and a fellowship in Medical Toxicology at the University of California San Diego in 2011. He has been faculty in the department of Emergency Medicine & Medical Toxicology at North Shore University Hospital since 2011, in Long Island, NY. He has been the Medical Toxicology Fellowship Director at Northwell Health since 2016, and his areas of specific interest include fellow education, metabolic uncouplers, overdose trends, and addiction medicine. He is dedicated to helping trainees achieve their individual career goals, as well as adapting his training program to the changing scope of practice for Medical Toxicologists, as well as the needs to individual learners. Outside of work, Dr. Nogar enjoys spending time with his wife & children. He is an avid fly-fisherman.

    J.J. Rasimas, PhD, MD, FAACT, FACLP, FACMT, FACPsych

    Professor of Psychiatry & Emergency Medicine

    Dalhousie University, University of Minnesota, & Penn State College of Medicine

    Dr. Rasimas has a Jesuit university background in biochemistry, mathematics, and philosophy. He completed the Medical Scientist Training Program, earning a PhD in chemical biology (2002) and MD (2003) from Penn State University. After Psychiatry residency at the Mayo Clinic, he was a clinical fellow at the National Institutes of Health in Washington, DC where he did translational research and trained in medical ethics. He also undertook formal education in psychoanalytic psychotherapy, completed the critical care based medical toxicology fellowship at Penn State, and became certified in Psychosomatic Medicine, Addiction Medicine, and Medical Toxicology. Further work at NIH has included the Undiagnosed Diseases Program and roles in research ethics and oversight. Dr. Rasimas was the Director of Consultation-Liaison Psychiatry and Co-Chair of the Biomedical Ethics Committee at Hennepin County Medical Center in Minneapolis, Minnesota before moving to Prince Edward Island, Canada in 2022. Based at Queen Elizabeth Hospital in Charlottetown, he served as the lead Psychiatrist for C-L and Addictions for the province. He has recently transitioned to Nova Scotia Health in an effort to build treatment programs for patients with complex psychosomatic illnesses and substance use. For PEI, Dr. Rasimas remains the Medical Director of the Atlantic Mentorship Network for Chronic Pain, Addictions, and Mental Illness. Dr. Rasimas is a university professor with continued involvement in medical education in both the US and Canada pursuing an academic medical career at the interface of psychosomatic medicine, medical toxicology, and psychodynamic psychotherapy with a primary clinical interest in the phenomenology of suicide.

    Daniel J. Sessions, MD, FACMT, FASAM, FAAEM

    Chief, Division of Medical Toxicology

    Ochsner Medical Center

    Dr. Sessions practices medical toxicology, emergency medicine and addiction medicine at Ochsner Health in the New Orleans area. Dr. Sessions has expertise in poisoning and drug overdose, envenomation, toxic occupational exposure, medication assisted therapy for opioid and alcohol use disorder and forensic toxicology. Dr. Sessions earned his degree in medicine from Louisiana State University School of Medicine in New Orleans in 2008. He is board-certified in emergency medicine and medical toxicology by the American Board of Emergency Medicine in 2012 and 2014. He completed a medical toxicology fellowship at the Rocky Mountain Poison & Drug Center at Denver health in Denver in 2013. He is board-certified in addiction medicine by the American Board of Preventative Medicine in 2022. Dr. Sessions actively participates in the American Academy of Emergency Medicine, the American College of Medical Toxicology, the American Academy of Clinical Toxicology and the American Society of Addiction Medicine.

    Sarah Shafer, MD

    Assistant Professor of Emergency Medicine and Medical Toxicology

    University of Iowa Department of Emergency Medicine

    Sarah Shafer, MD, is an assistant professor of emergency medicine and medical toxicology at University of Iowa Department of Emergency Medicine in Iowa City. You may know her through her twitter handle @toxiferoustales.

    Jerry W. Snow, MD

    Associate Professor of Emergency & Internal Medicine

    Banner – University Medical Center Phoenix

    Dr. Jerry Snow serves as the Program Director for the Medical Toxicology Fellowship and holds the position of Associate Professor in both Emergency Medicine and Internal Medicine at Banner – University Medical Center Phoenix. Actively engaged, he contributes to key committees such as the Banner Critical Care Committee, Banner Behavioral Health Clinical Consensus Group, Department of Medical Toxicology Clinical Competency Committee, and the Addiction Medicine Section. Nationally, Dr. Snow is involved with the ACMT Education Committee, actively participating in the Board Review Course.

    Alaina R. Steck, MD, FACMT, FASAM (Moderator)

    Associate Professor of Emergency Medicine

    Emory University

    Dr. Alaina Steck is an Associate Professor of Emergency Medicine in the Emory School of Medicine and the Medical Director of Grady Memorial Hospital's oupatient OUD treatment clinic. She is board-certified in Emergency Medicine, Medical Toxicology, and Addiction Medicine, and actively practices all three specialties at Grady Memorial Hospital in Atlanta. She is on the advisory boards of the Christopher White Crusade and YourPath Health. Her research and clinical efforts focus on transitions of care from the Emergency Department, integration of Addiction Medicine care with other specialty services (e.g., Orthopedics, Trauma Surgery, and Infectious Diseases), and the impact of OUD treatment on health care utilization.

    Samuel J. Stelpflug, MD, FACMT

    Director, Twin Cities Medical Toxicology Fellowship

    University of Minnesota Medical School

    Dr. Stellpflug is a Medical Toxicologist and Emergency Physician within the HealthPartners hospital system in MN and WI. He provides consultation for the Minnesota Poison Control System, and his academic appointment is through the University of Minnesota Medical School. Following medical school at the University of Wisconsin he completed a residency in emergency medicine at Regions Hospital and then the medical toxicology fellowship in the Twin Cities, a joint effort between the Regions Hospital / HealthPartners and the Minnesota Poison Control System.

    Joshua Trebach, MD (Moderator)

    Emergency Medicine Physician & Medical Toxicologist

    University of Iowa Hospitals and Clinics

    Josh Trebach is an emergency medicine physician and medical toxicologist at the University of Iowa Hospital and Clinics. He completed his undergraduate training at Virginia Tech, medical school training and residency at Johns Hopkins, and toxicology fellowship at New York University/New York City Poison Control Center. Josh is currently the Director of Resident Medical Toxicology Education at the University of Iowa and is passionate about all things toxicology, medical education, social media, LGBTQ health, and animal rescue.

    Stephanie Weiss, MD, PhD

    Staff Clinician, Translational Addiction Medicine Branch

    National Institute on Drug Abuse

    Dr. Stephanie Weiss is the Staff Research Physician serving the Translational Addiction Medicine Branch of the National Institute on Drug Abuse’s Intramural Research Program. After earning a Ph.D. in pharmaceutical chemistry, Dr. Weiss received her medical degree in 2011.  She is board certified in emergency medicine, addiction medicine, and medical toxicology and was selected to participate in the Boston University Research in Addiction Medicine Scholars Program prior to joining NIDA.  Dr. Weiss is responsible for providing optimal, safe, and ethical care to study participants and clinical support toward the TAMB mission conducting inpatient and outpatient proof-of-concept human laboratory studies. Her research interests include novel psychoactive substances, medication misuse, and improving interpretation of urine drug testing.

    Interactive Cram Sessions


    Interactive Cram Session #1

    Friday, June 14, 2024, 12:00-1:00 PM ET

    • Pharmacokinetics & Toxicokinetics
    • Neurotoxins & Anticonvulsants
    • Pediatric Toxicity
    • Anesthetics, NMBs & Muscle Relaxants
    • Analytics & Forensics

    Interactive Cram Session #2

    Friday, June 28, 2024, 12:00-1:00 PM ET

    • The Toxic House
    • Poisonous Plants
    • Warfare/Terrorism
    • Chemotherapeutics
    • Pesticides

    Interactive Cram Session #3

    Friday, July 12, 2024, 12:00-1:00 PM ET

    • Hydrocarbons
    • Alcohols & Glycols
    • Aquatic Toxicity
    • Radiation
    • Cardiovascular Toxins

    Interactive Cram Session #4

    Friday, July 26, 2024, 12:00-1:00 PM ET

    • Classic Toxicology
    • Antipsychotics
    • Psychotropics
    • Endocrine
    • Metals & Metalloids

    Interactive Cram Session #5

    Friday, August 9, 2024, 12:00-1:00 PM ET

    • Inhalational Toxins & Asphyxiants
    • Carcinogenesis
    • Reproductive & Developmental Tox
    • Epidemiology & Population Health
    • Statistical Measures

    Interactive Cram Session #6

    Friday, August 23, 2024, 12:00-1:00 PM ET

    • Herbals, Vitamins & Supplements
    • Terrestrial Toxicity
    • Hematology
    • Antimicrobials
    • Drugs of Abuse & Withdrawal

    Interactive Cram Session #7

    Friday, September 6, 2024, 12:00-1:00 PM ET

    • Gastroenterology
    • Mushrooms & Fungal Toxins
    • Clinical Drug Testing & Diagnostics
    • Dermatology & Pathology
    • Miscellaneous Toxins
    • Register
      • Non-member - Tier I - $1,750
      • Non-member - Tier II - $1,750
      • Non-member - Tier III - $1,750
      • Non-member - Tier IV - $1,750
      • Member - Tier I - $1,500
      • Member - Tier II - $1,500
      • Member - Tier III - $1,500
      • Member - Tier IV - $1,500
    • More Information
  • Contains 2 Component(s)

    Case 1: A 30-year-old woman presents to the ED with a rash that started after she took a medication to treat a toothache. On arrival to the ED she is febrile and tachycardic. Case 2:​ A 62-year-old woman is found unresponsive and covered in vomit. On arrival to the ED, she is obtunded, hypothermic, and hypotensive. Case 3: ​A 3-year-old boy with developmental delay is found playing with a common household object. When his father realizes he has ingested almost half of it, he washes out the child’s mouth and brings him to the ED.

    NCC - 6/2024

    Case 1: A 30-year-old woman presents to the ED with a rash that started after she took a medication to treat a toothache. On arrival to the ED she is febrile and tachycardic.
    Case 2: A 62-year-old woman is found unresponsive and covered in vomit. On arrival to the ED, she is obtunded, hypothermic, and hypotensive.  
    Case 3: A 3-year-old boy with developmental delay is found playing with a common household object. When his father realizes he has ingested almost half of it, he washes out the child’s mouth and brings him to the ED. 

    Series Moderator: Lewis Nelson, MD, FACMT, Rutgers New Jersey Medical School, Newark, NJ

    About The Series: ACMT's National Case Conference (NCC) is a monthly webinar for ACMT members that features interesting cases seen by medical toxicologists nationwide. NCC is an educational endeavor and a quality improvement effort intended to improve patient care. It is not intended to define standard of care. Attempts have been made to ensure HIPAA compliance. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.

    This webinar is for ACMT members only.

    Lewis Nelson, MD, MBA, FACMT, FASAM

    Chair of Emergency Medicine

    Rutgers New Jersey Medical School

    Lewis S. Nelson, MD is Professor and Chair of the Department of Emergency Medicine at Rutgers New Jersey Medical School, Chief of Service for the Emergency Department at University Hospital of Newark, and Senior Consultant to the New Jersey Poison Information & Education System. Dr. Nelson is board certified in emergency medicine, medical toxicology, and addiction medicine. His areas of specific interest include preventing and managing the consequences of opioid and other substance use, multimodal pain management strategies, health policy, and medication safety.

    Dr. Nelson has served as President of American College of Medical Toxicology and on the Board of Directors of both the American Board of Emergency Medicine and the Accreditation Council for Continuing Medical Education. He is currently the president of Association of Academic Chairs in Emergency Medicine. He is a long time consultant for several governmental agencies including the Centers for Disease Control and Prevention, the Department of Homeland Security, and the Food and Drug Administration. He is an editor of the textbook “Goldfrank’s Toxicologic Emergencies.

  • Contains 2 Component(s)

    Alphabet Soup of Regulatory Toxicology

    Alphabet Soup of Regulatory Toxicology

    Presenter: Michael Holland, MD, FACMT, FAACT, FEACCT, FACOEM, FACEP, SUNY Upstate Medical University, Syracuse, NY

    Learning Objectives

    • Describe how several occupational disasters shaped the occupational and regulatory toxicology landscape.
    • Understand why OSHA used then-current ACGIH TLVs in 1970 as its initial set of PELs for workplace regulations.
    • Contrast the different airborne exposure concentrations allowed for workers by regulatory statute (OSHA PEL) versus the recommended exposure concentrations for the general public used by first responders (AEGL, ERPG).

    About The Series: ACMT's Grand Rounds offer an in-depth and interactive platform for learning and discussion about issues that impact the research and practice of medical toxicology. Experts from within and outside medical toxicology will share their knowledge and experience and highlight areas for collaboration and mutual understanding.

    This webinar is for ACMT members only.

    Michael G. Holland, MD, FEAPCCT, FAACT, FACOEM, FACMT, FACEP

    Professor of Emergency Medicine

    SUNY Upstate Medical University

    Dr. Holland is Clinical Professor of Emergency Medicine at SUNY Upstate Medical University in Syracuse, NY where he is on the faculty of the Medical Toxicology Fellowship Training Program and is a Consulting Medical Toxicologist at the Upstate New York Poison Center and the Onondaga County Medical Examiner’s Office-both in Syracuse, NY. Dr. Holland is also the Director of Occupational Medicine for the Saratoga Hospital Medical Group, and is the Saratoga Hospital Employee Health Medical Director, where he oversees the health and safety of over 3100 employees and staff. He also serves as Employee Health Medical Director at Glens Falls Hospital in Glens Falls, NY, covering 2500 employees. He is also Principal Medical Toxicologist at the Center for Toxicology and Environmental Health (CTEH) in Little Rock, AR.    

  • Contains 1 Component(s)

    X-Factor - Xylazine

    X-Factor - Xylazine

    In this episode Dr. Gillian Beauchamp sits down with Dr. Matthew Salzman discusses the complications associated with use of fentanyl containing xylazine from wounds to withdrawal. 

    ACMT members Gillian Beauchamp, MD, and Elizabeth (Elissa) Moore, DO deliver evidence-based medical toxicology core content and trending topics in easily digestible bites. Visit toxinten.com and follow on Twitter @toxinten.

    Gillian Beauchamp, MD, FACMT, FASAM (Moderator)

    Program Director, Medical Toxicology Fellowship; Associate Professor

    Lehigh Valley Health Network; USF Morsani College of Medicine

    Gillian Beauchamp, MD, is fellowship director for the Lehigh Valley Health Network (LVHN) Medical Toxicology fellowship; core faculty for the LVHN emergency medicine residency; Associate professor, USF Morsani College of Medicine; LVHN Medical director for acute care substance use and prevention; Co-chair, LVHN Opioid Stewardship and Linkage to Treatment Committee; and Vice Chair for Education and Community Engagement in the Lehigh Valley Health Network Department of Emergency and Hospital Medicine. She is board certified in Emergency Medicine, Medical Toxicology and Addiction Medicine. She is an Editorial board member for Toxicology Communications and a Reviews Section Editor and Editorial board member for the Journal of Medical Toxicology; She is co-host for the Tox in Ten: ACMT Highlights podcast and oversees the ACMT online toxicology lecture library as a member of the ACMT Education Committee.

    Matthew Salzman, MD

    Assistant Professor

    Cooper Medical School of Rowan University

    Matthew Salzman received his Bachelor of Arts in Music from the University of Rochester and his Medical Degree from the Sidney Kimmel Medical College at Thomas Jefferson University.  He trained in Emergency Medicine and Medical Toxicology at Drexel University College of Medicine.  Currently, he is an Assistant Professor of Emergency Medicine in the Division of Medical Toxicology and Addiction Medicine at Cooper Medical School of Rowan University.  He is the Medical Director for the In-patient Addiction Medicine Consult service as well as Medical Director for Research for Addiction Medicine at Cooper.  He is also a volunteer consultant in toxicology for the Children's Hospital of Philadelphia and the Philadelphia Poison Control Center.

    • Register
      • Non-member - Tier I - Free!
      • Non-member - Tier II - Free!
      • Non-member - Tier III - Free!
      • Non-member - Tier IV - Free!
      • Member - Tier I - Free!
      • Member - Tier II - Free!
      • Member - Tier III - Free!
      • Member - Tier IV - Free!
    • More Information
  • Contains 6 Component(s)

    The Asthma Ready Communities modules cover six main topics relevant to understanding and managing asthma.

    The Asthma Ready Communities Education Series is presented in two parts and covers six main topics relevant to understanding and managing asthma.

    • Asthma Overview Part 1 addresses What is asthma?, Asthma Signs and Symptoms, and Asthma Triggers.
    • Asthma Overview Part 2 addresses Asthma Medications, Inhalation Technique, and Asthma Action Plans.

    These educational modules were developed with support from both the Mid-America Pediatric Environmental Health Specialty Unit and the Asthma Ready Communities at the University of Missouri.

    image
    image    

    Mid-America Pediatric Environmental Health Specialty Unit

    These videos were supported by cooperative agreement FAIN: NU61TS000296 from the Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry (CDC/ATSDR). The U.S. Environmental Protection Agency (EPA) provided support through Inter-Agency Agreement DW-75-95877701 with CDC/ATSDR. The American Academy of Pediatrics supports the Pediatric Environmental Health Specialty Units as the National Program Office. The findings and conclusions in this presentation have not been formally disseminated by CDC/ATSDR or EPA and should not be construed to represent any agency determination or policy. Use of trade names that may be mentioned is for identification only and does not imply endorsement by the CDC/ATSDR or EPA.

    Asthma Ready® Communities, University of Missouri 

    Funding for these videos were also provided in part by the US Centers for Disease Control and Prevention cooperative agreement number NUE1EH001393. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.

    Course Syllabus | Asthma Overview, Part 1 & 2


    Asthma Overview | Part 1

    Asthma Overview: Part 1, includes three sections: What is Asthma?, Asthma Signs and Symptoms, and Asthma Triggers.

    What is asthma?

    This first section explains what asthma is and how it affects breathing. It will show short cartoon messages (vignettes) that cover asthma concepts and how to improve asthma control. It also includes illustrations of a normal airway vs changes in the airway of someone with asthma that is not well controlled and introduces the concept of environmental triggers. Upon completion, the learner should be able to:

    • Describe the main components of asthma and how it affects breathing
    • Describe environmental triggers and their effects on the airways
    • Explain what measures can be used so asthma is well controlled

    Asthma Signs and Symptoms

    This second section discusses common asthma signs and symptoms of an asthma episode, how asthma control is defined, and the importance of asthma education, particularly in recognizing the symptoms of an episode (or can be referred to as an attack, flare, or exacerbation) and prompt treatment. Upon completion, the learner should be able to:

    • Describe at least three common symptoms of asthma
    • Define ways to assess asthma symptoms and interference with activities
    • Describe how asthma control is defined

    Asthma Triggers 

    Preventing signs and symptoms is important in asthma management, and one component of that is trigger avoidance or reduction. This third section discusses asthma triggers – what they are, provides some examples, and where they are commonly found. Upon completion, the learner should be able to:

    • Describe how asthma triggers cause symptoms
    • Define types of triggers
    • List common asthma triggers and some reduction and remediation strategies

    Asthma Overview | Part 2 

    Asthma Overview: Part 2, includes three sections: Asthma Medications, Inhalation Technique, and Asthma Action Plans.

    Asthma Medications

    The fourth section identifies the different types of asthma medications including quick relief, control, and emergency medicines and when to use these medications. Upon completion, the learner should be able to:

    • Identify the different types of medicines used to treat asthma
    • Discuss when to take asthma medication
    • Explain some common side effects of asthma medication and measures to reduce these side effects

    Inhalation Technique

    The fifth section reviews how inhaler medication should be taken and the importance of using a valved holding chamber with a metered-dose inhaler (MDI). This module also shows an inhalation coaching session. Upon completion, the learner should be able to:

    • Discuss why good inhalation technique is needed when taking inhaler medication
    • Explain why using a valved holding chamber (a type of spacer) is useful with a metered-dose inhalers 
    • Describe why a daily inhaled corticosteroid is so important to control asthma

    Asthma Action Plans

    An asthma action plan (AAP) is a tool that guides how to manage asthma, recognize symptom severity, and what steps should be taken to respond to the symptoms. The plan is organized like a traffic light. The sixth section discusses what an AAP is, its purpose, how it is used, and how to interpret the green, yellow, and red zones. Upon completion, the learner should be able to:

    • Describe the three zones of an asthma action plan
    • Explain what actions should be taken in each zone
    • Describe the signs and symptoms when emergency care is required
    • List which members of the care team should have a copy of the AAP

    Rebecca Brown MPA, AE-C, RRT

    Respiratory Therapist, Certified Asthma Educator

    Rebecca Brown, MPA, RRT, AE-C, is a respiratory therapist and certified asthma educator. A respiratory therapist since 2001, and a certified asthma educator since 2014, she coordinates community-based asthma education delivery with schools and clinics. This coordination involves training, ongoing support, and practice facilitation to school nurses and clinicians to increase their understanding and delivery of self-management asthma educations. She has been working with Asthma Ready Communities as a Regional Coordinator in Kansas City Region since 2012, and through this partnership, has also worked with school districts with the Missouri Asthma Prevention and Control Program. Within the Asthma Care Accelerator ECHO Program, Rebecca serves as the Asthma Day Coordinator.

    • Register
      • Non-member - Tier I - Free!
      • Non-member - Tier II - Free!
      • Non-member - Tier III - Free!
      • Non-member - Tier IV - Free!
      • Member - Tier I - Free!
      • Member - Tier II - Free!
      • Member - Tier III - Free!
      • Member - Tier IV - Free!
    • More Information